Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds

Garry J. Southan, Andrew L. Salzman, Csaba Szabo

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The generation of nitric oxide (NO) by nitric oxide synthase (NOS) can be inhibited by certain guanidines and S-alkylisothioureas. In particular, aminoethylisothiourea (AE-TU) shows selectivity towards the inducible isoform (iNOS) over the endothelial isoform (ecNOS). Here we report on the effects of the selenium analog of AE-TU, aminoethylisoselenourea (AE-SeU), and its homologue, aminopropylisoselenourea (AP-SeU), on the activities of iNOS and ecNOS. AE-SeU and AP-SeU inhibited the conversion of L-arginine to L-citrulline in homogenates of lung taken from endotoxin-treated rats (a model of iNOS activity) with potencies (EC50 = 1.1, and 0.1 μM, respectively) greater than that of N(G)-methyl-L-arginine (L-NMA) (22 μM). In contrast, AE-SeU and AP-SeU were weaker than or similar to L-NMA at inhibiting ecNOS activity in homogenized bovine endothelial cells (EC50 values = 104, 15, and 16 μM, respectively). AE-SeU and AP-SeU potently inhibited nitrite formation by immunostimulated J774 macrophages (a model of iNOS activity) with EC50 values of 10 and 4 μM respectively. The corresponding EC50 value for L-NMA was 160 μM. The inhibition was dose-dependently reduced by increasing concentrations of L-arginine in the medium. In vivo, AE-SeU had only modest effects on blood pressure when given as a bolus to anesthetized rats, suggesting only a small effect on ecNOS in vivo, whereas AP-SeU had potent presser effects similar to those of L-NMA. We found that both AE-SeU and AP-SeU were unstable in aqueous solution at pH values above 6. Their disappearance from solution was accompanied by the appearance of a reductive species, probably free selenol. These findings suggest that AE-SeU and AP-SeU exert their inhibitory effects through intramolecular rearrangement to yield selenoethylguanidine and seleno-propylguanidine. Thus, selenoalkylguanidines are novel inhibitors of iNOS.

Original languageEnglish (US)
Pages (from-to)1139-1148
Number of pages10
JournalLife Sciences
Volume58
Issue number14
DOIs
StatePublished - Mar 1 1996
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type II
Nitric Oxide Synthase
Protein Isoforms
Arginine
Rats
Guanidines
Citrulline
Macrophages
Endothelial cells
Blood pressure
Selenium
Nitrites
aminoethylisoselenouronium
Endotoxins
Nitric Oxide
Endothelial Cells
Blood Pressure
Lung

Keywords

  • Aminoalkylselenoureas
  • Blood pressure
  • Nitric oxide synthase inhibitor
  • Selenoalkylguanidines

ASJC Scopus subject areas

  • Pharmacology

Cite this

Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds. / Southan, Garry J.; Salzman, Andrew L.; Szabo, Csaba.

In: Life Sciences, Vol. 58, No. 14, 01.03.1996, p. 1139-1148.

Research output: Contribution to journalArticle

Southan, Garry J. ; Salzman, Andrew L. ; Szabo, Csaba. / Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds. In: Life Sciences. 1996 ; Vol. 58, No. 14. pp. 1139-1148.
@article{679b56ad6be24774b4f97506cb21bc7c,
title = "Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds",
abstract = "The generation of nitric oxide (NO) by nitric oxide synthase (NOS) can be inhibited by certain guanidines and S-alkylisothioureas. In particular, aminoethylisothiourea (AE-TU) shows selectivity towards the inducible isoform (iNOS) over the endothelial isoform (ecNOS). Here we report on the effects of the selenium analog of AE-TU, aminoethylisoselenourea (AE-SeU), and its homologue, aminopropylisoselenourea (AP-SeU), on the activities of iNOS and ecNOS. AE-SeU and AP-SeU inhibited the conversion of L-arginine to L-citrulline in homogenates of lung taken from endotoxin-treated rats (a model of iNOS activity) with potencies (EC50 = 1.1, and 0.1 μM, respectively) greater than that of N(G)-methyl-L-arginine (L-NMA) (22 μM). In contrast, AE-SeU and AP-SeU were weaker than or similar to L-NMA at inhibiting ecNOS activity in homogenized bovine endothelial cells (EC50 values = 104, 15, and 16 μM, respectively). AE-SeU and AP-SeU potently inhibited nitrite formation by immunostimulated J774 macrophages (a model of iNOS activity) with EC50 values of 10 and 4 μM respectively. The corresponding EC50 value for L-NMA was 160 μM. The inhibition was dose-dependently reduced by increasing concentrations of L-arginine in the medium. In vivo, AE-SeU had only modest effects on blood pressure when given as a bolus to anesthetized rats, suggesting only a small effect on ecNOS in vivo, whereas AP-SeU had potent presser effects similar to those of L-NMA. We found that both AE-SeU and AP-SeU were unstable in aqueous solution at pH values above 6. Their disappearance from solution was accompanied by the appearance of a reductive species, probably free selenol. These findings suggest that AE-SeU and AP-SeU exert their inhibitory effects through intramolecular rearrangement to yield selenoethylguanidine and seleno-propylguanidine. Thus, selenoalkylguanidines are novel inhibitors of iNOS.",
keywords = "Aminoalkylselenoureas, Blood pressure, Nitric oxide synthase inhibitor, Selenoalkylguanidines",
author = "Southan, {Garry J.} and Salzman, {Andrew L.} and Csaba Szabo",
year = "1996",
month = "3",
day = "1",
doi = "10.1016/0024-3205(96)00072-0",
language = "English (US)",
volume = "58",
pages = "1139--1148",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "14",

}

TY - JOUR

T1 - Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds

AU - Southan, Garry J.

AU - Salzman, Andrew L.

AU - Szabo, Csaba

PY - 1996/3/1

Y1 - 1996/3/1

N2 - The generation of nitric oxide (NO) by nitric oxide synthase (NOS) can be inhibited by certain guanidines and S-alkylisothioureas. In particular, aminoethylisothiourea (AE-TU) shows selectivity towards the inducible isoform (iNOS) over the endothelial isoform (ecNOS). Here we report on the effects of the selenium analog of AE-TU, aminoethylisoselenourea (AE-SeU), and its homologue, aminopropylisoselenourea (AP-SeU), on the activities of iNOS and ecNOS. AE-SeU and AP-SeU inhibited the conversion of L-arginine to L-citrulline in homogenates of lung taken from endotoxin-treated rats (a model of iNOS activity) with potencies (EC50 = 1.1, and 0.1 μM, respectively) greater than that of N(G)-methyl-L-arginine (L-NMA) (22 μM). In contrast, AE-SeU and AP-SeU were weaker than or similar to L-NMA at inhibiting ecNOS activity in homogenized bovine endothelial cells (EC50 values = 104, 15, and 16 μM, respectively). AE-SeU and AP-SeU potently inhibited nitrite formation by immunostimulated J774 macrophages (a model of iNOS activity) with EC50 values of 10 and 4 μM respectively. The corresponding EC50 value for L-NMA was 160 μM. The inhibition was dose-dependently reduced by increasing concentrations of L-arginine in the medium. In vivo, AE-SeU had only modest effects on blood pressure when given as a bolus to anesthetized rats, suggesting only a small effect on ecNOS in vivo, whereas AP-SeU had potent presser effects similar to those of L-NMA. We found that both AE-SeU and AP-SeU were unstable in aqueous solution at pH values above 6. Their disappearance from solution was accompanied by the appearance of a reductive species, probably free selenol. These findings suggest that AE-SeU and AP-SeU exert their inhibitory effects through intramolecular rearrangement to yield selenoethylguanidine and seleno-propylguanidine. Thus, selenoalkylguanidines are novel inhibitors of iNOS.

AB - The generation of nitric oxide (NO) by nitric oxide synthase (NOS) can be inhibited by certain guanidines and S-alkylisothioureas. In particular, aminoethylisothiourea (AE-TU) shows selectivity towards the inducible isoform (iNOS) over the endothelial isoform (ecNOS). Here we report on the effects of the selenium analog of AE-TU, aminoethylisoselenourea (AE-SeU), and its homologue, aminopropylisoselenourea (AP-SeU), on the activities of iNOS and ecNOS. AE-SeU and AP-SeU inhibited the conversion of L-arginine to L-citrulline in homogenates of lung taken from endotoxin-treated rats (a model of iNOS activity) with potencies (EC50 = 1.1, and 0.1 μM, respectively) greater than that of N(G)-methyl-L-arginine (L-NMA) (22 μM). In contrast, AE-SeU and AP-SeU were weaker than or similar to L-NMA at inhibiting ecNOS activity in homogenized bovine endothelial cells (EC50 values = 104, 15, and 16 μM, respectively). AE-SeU and AP-SeU potently inhibited nitrite formation by immunostimulated J774 macrophages (a model of iNOS activity) with EC50 values of 10 and 4 μM respectively. The corresponding EC50 value for L-NMA was 160 μM. The inhibition was dose-dependently reduced by increasing concentrations of L-arginine in the medium. In vivo, AE-SeU had only modest effects on blood pressure when given as a bolus to anesthetized rats, suggesting only a small effect on ecNOS in vivo, whereas AP-SeU had potent presser effects similar to those of L-NMA. We found that both AE-SeU and AP-SeU were unstable in aqueous solution at pH values above 6. Their disappearance from solution was accompanied by the appearance of a reductive species, probably free selenol. These findings suggest that AE-SeU and AP-SeU exert their inhibitory effects through intramolecular rearrangement to yield selenoethylguanidine and seleno-propylguanidine. Thus, selenoalkylguanidines are novel inhibitors of iNOS.

KW - Aminoalkylselenoureas

KW - Blood pressure

KW - Nitric oxide synthase inhibitor

KW - Selenoalkylguanidines

UR - http://www.scopus.com/inward/record.url?scp=0029926451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029926451&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(96)00072-0

DO - 10.1016/0024-3205(96)00072-0

M3 - Article

C2 - 8614265

AN - SCOPUS:0029926451

VL - 58

SP - 1139

EP - 1148

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 14

ER -